en

PRODUCT DETAIL

ABSIMKY 130 mg koncentrát na infúzny roztok

Code 8472E
MA number EU/1/24/1880/003
Product Form: con inf 1x26 ml/130 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Accord Healthcare S.L.U, Spain
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AC Interleukin inhibitors
L04AC05 Ustekinumab
Shelf life: 18
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(4) similar biological application
MA issued: 12.12.2024
Validity: 12.12.2029
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 09.01.2025
eu-flag.png sk-flag.png